DWI-MRI improves treatment response prediction for cervical cancer
Thursday, November 30 | 3:10 p.m.-3:20 p.m. | R1-SSRO04-6 | Room S502In this presentation, researchers will demonstrate how diffusion-weighted imaging MRI (DWI-MRI) may enhance chemoradiotherapy response prediction of early treatment timepoints for cervical cancer.In her talk, Megan Jacobsen, PhD, from University of Texas MD Anderson Cancer Center, will talk about her team’s research, which found that apparent diffusion coefficient data from DWI-MRI showed slightly less restricted diffusion during the first two weeks of chemoradiotherapy in women with favorable human papillomavirus (HPV) circulating tumor DNA response,...
Source: AuntMinnie.com Headlines - November 16, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 MRI Preview Source Type: news
Cervical Cancer Elimination Day of Action: For the first time in history, a cancer can be ...
On November 17, 2023, the world will mark three years of the global collaboration with survivors, leaders, and advocates towards the elimination of cervical cancer. This provides an opportunity to celebrate the global commitment and review progress on the pathway to elimination, aiming for a threshold of fewer than 4 women per 100 000 women-years. This has catalyzed a social movement and sparked an annual tradition, bringing communities across the world together for a “Day of Action for Cervical Cancer Elimination”.
Cervical cancer is a worldwide health concern. Cervical cancer claims the lives of 300,000 women worldw...
Source: WHO EMRO News - November 15, 2023 Category: Middle East Health Source Type: news
Nigeria: Cervical Cancer Vaccine - a Welcome Development
[Daily Trust] In the largest single round of Human Papillomavirus (HPV) vaccination in Africa, Nigeria on Tuesday, October 24, 2023, introduced the vaccine into its routine immunization system, aiming to reach 7.7 million girls to stem the menace of cervical cancer among women. Mostly caused by the HPV, parents can avoid the physical and financial pains of the disease by protecting their young girls with a single dose of the vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 14, 2023 Category: African Health Tags: Health and Medicine Noncommunicable Diseases Nigeria West Africa Source Type: news
Nigeria: Nigeria Begins Mass Hpv Vaccinations to Fight Cervical Cancer
[Ghanaian Times] Nigeria has begun a mass vaccination campaign against human papillomavirus (HPV) in a bid to drastically reduce cervical cancer rates. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
Nigeria: What to Know About HPV Vaccine
[Daily Trust] Today the federal government will be introducing the Human Papillomavirus (HPV) vaccine into the country's immunization programme for girls between ages 9 and 14 years. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
Most women are in the dark over cervical screening and the vital testing that goes with it, charity warns
Under NHS screening, cervical samples taken during smear tests are examined for human papillomavirus (HPV). (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2023 Category: Consumer Health News Source Type: news
Study Confirms Better Survival for HPV-Positive Cervical Cancer
(MedPage Today) -- Cervical cancer associated with detectable human papillomavirus (HPV+) RNA or DNA had significantly better outcomes, including survival, a large meta-analysis of published studies showed.
Patients who tested positive for HPV... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 27, 2023 Category: Hematology Source Type: news
Methylation Score Can ID Risk for Cervical Adenocarcinomas
WEDNESDAY, Sept. 13, 2023 -- A methylation score, composed of the average methylation percentage across 35 CpG sites in the L2/L1 open reading frames of human papillomavirus (HPV)16, 18, and 45, and two human loci, can identify the risk for cervical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news
Most Patients Don't Realize HPV Causes Throat Cancer, Survey Finds
(MedPage Today) -- Most respondents to a survey conducted at an academic medical center were not informed of the relationship between human papillomavirus (HPV) and throat cancer by their healthcare providers, a study showed.
Among 271 respondents... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 5, 2023 Category: Hematology Source Type: news
Africa: One in Three Men Worldwide Are Infected With Genital Human Papillomavirus
[WHO] A new study has been published in The Lancet Global Health showing that almost 1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high risk, or oncogenic, HPV types. These estimates show that men frequently harbour genital HPV infections and emphasize the importance of incorporating men in efforts to control HPV infection and reduce the incidence of HPV related disease in both men and women. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 1, 2023 Category: African Health Tags: Africa External Relations Health and Medicine International Organizations and Africa Women and Gender Source Type: news
Teen HPV Vaccine Rates Stall for First Time in a Decade
(MedPage Today) -- After rising steadily since 2013, new human papillomavirus (HPV) vaccinations in teens stalled for the first time in 10 years, a CDC report showed.
The proportion of 13- to 17-year-olds who received at least one dose of HPV... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 25, 2023 Category: Hematology Source Type: news
U.S. Kids ’ HPV Vaccination Rate Has Stalled
THURSDAY, Aug. 24, 2023 -- For the first time in a decade, the rate at which American adolescents received the human papillomavirus (HPV) vaccine has not increased, new data show.
Current guidelines from the U.S. Centers for Disease Control and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2023 Category: General Medicine Source Type: news
Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
MONDAY, July 31, 2023 -- For nonpediatric specialties, return margins for human papillomavirus (HPV) vaccine costs by private payers are small, according to a study published in the July/August issue of the Annals of Family Medicine.
Yenan Zhu,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2023 Category: Pharmaceuticals Source Type: news
Nepal Poised To Start HPV Vaccination To Prevent Cervical Cancer, Awaiting GAVI
As Dipak Subedi was organizing a vaccination programme against the human papillomavirus (HPV) in the city of Bharatpur in Chitwan district of southern Nepal he was getting phone calls from neighbouring districts asking if he had extra doses available — people were willing to travel for hours to get their girls vaccinated against HPV, which […] (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - July 31, 2023 Category: International Medicine & Public Health Authors: Marty Logan Tags: Asia-Pacific Gender Headlines Health TerraViva United Nations human papillomavirus (HPV) Source Type: news
What Are Treatments for Recurrent Respiratory Papillomatosis?
Discussion
Human papilloma virus (HPV) is a member of the Papillomaviridae virus family with over a 150 different subtypes. HPV can cause cervical, genital and respiratory tract papillomas. HPV is often benign but can cause anogenital, cervical and head and neck cancers.
Recurrent respiratory papillomatosis (RRP) is uncommon but can cause significant morbidity while awaiting the body’s immune system to respond. There is a juvenile and adult form, and the incidence varies between 2-4/100,000 in the pediatric population. The juvenile form frequently occurs between 3.6-6 years of age and in general the younger the patie...
Source: PediatricEducation.org - July 31, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
